We lead research addressing primary care and correctional populations, opioid and alcohol use disorders, and addiction pharmacotherapies—focusing on real-world outcomes such as overdose prevention and treatment retention.

Research Initiatives

Our team is engaged in the following research studies:

• Long-Acting Buprenorphine Versus Naltrexone Opioid Treatments in CJS-Involved Adults

• Impact of Jail-Based Methadone in New York City from 2012–2017

• Opioid Use Disorder Treatment Evidence Map

• Buprenorphine Extended-Release Versus Daily Sublingual Buprenorphine-Naloxone Pilot

• Extended-Release Naltrexone as Opioid Relapse Prevention

• Extended-Release Versus Oral Naltrexone for Treating Alcohol Dependence in Primary Care

• Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention

Fellowship Research Training

Through the NYU Grossman School of Medicine Addiction Medicine Fellowship, our lab offers fellows the opportunity to participate in health services and clinical trial research, both in the lab and at clinical training sites at NYC Health + Hospitals/Bellevue.